Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mary O. Stevenson"'
Autor:
Pichatorn Suppakitjanusant, Yuhan Ji, Mary O. Stevenson, Panicha Chantrapanichkul, R. Craig Sineath, Michael Goodman, Jessica A. Alvarez, Vin Tangpricha
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 21, Iss , Pp 100230- (2020)
Introduction: Many transgender people take hormone therapy to affirm their gender identity. One potential long-term consequence of gender affirming hormone therapy is increased body mass index (BMI), which may be associated with metabolic syndrome, c
Externí odkaz:
https://doaj.org/article/c6ab0b94649d46aa871254dae75c2896
Autor:
Mary O. Stevenson, Vin Tangpricha
Publikováno v:
A Case-Based Guide to Clinical Endocrinology ISBN: 9783030843663
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3b4c1f4c6f6fb2e7c77ab73eb697de5
https://doi.org/10.1007/978-3-030-84367-0_56
https://doi.org/10.1007/978-3-030-84367-0_56
Autor:
Mary O. Stevenson, Vin Tangpricha
Publikováno v:
Endocrinology and Diabetes ISBN: 9783030906832
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f26fdee49caa96e4dd8bed37bf55eaf
https://doi.org/10.1007/978-3-030-90684-9_15
https://doi.org/10.1007/978-3-030-90684-9_15
Autor:
Vin Tangpricha, Michael Goodman, Panicha Chantrapanichkul, Pichatorn Suppakitjanusant, Mary O. Stevenson
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 27(1)
To examine the association of various gender-affirming hormone therapy regimens with blood sex hormone concentrations in transgender individuals.This retrospective study included transgender people receiving gender-affirming hormone therapy between J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::745ea7e62f48d9d82491d90de4cf311d
https://pubmed.ncbi.nlm.nih.gov/33832718
https://pubmed.ncbi.nlm.nih.gov/33832718
Publikováno v:
Journal of the Endocrine Society
Purpose Transgender and gender-nonconforming individuals have unique health care needs and have difficulty accessing health care services because of a lack of qualified health care providers, insurance coverage, mistreatment, and bias by the medical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96704af314f4a5a460232fafbfd60c51
https://doi.org/10.1210/jendso/bvz007
https://doi.org/10.1210/jendso/bvz007
Autor:
Mary O. Stevenson, Vin Tangpricha
Publikováno v:
Endocrinol Metab Clin North Am
PURPOSE OF REVIEW: To summarize the current studies, systematic reviews, and clinical practice guidelines pertaining to the screening, diagnosis, and treatment of osteoporosis in transgender persons. RECENT FINDINGS: Gender affirming hormone therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::902f7ed03265b11edf8f5439507bb8de
https://pubmed.ncbi.nlm.nih.gov/31027549
https://pubmed.ncbi.nlm.nih.gov/31027549
Publikováno v:
Endocrine Practice. 25:201-202
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d75fd597bba3cdcdf2c1eb620bdf964
https://doi.org/10.1016/s1530-891x(20)46768-0
https://doi.org/10.1016/s1530-891x(20)46768-0
Publikováno v:
Transgender Health
Transgender Health, Vol 1, Iss 1, Pp 202-204 (2016)
Transgender Health, Vol 1, Iss 1, Pp 202-204 (2016)
Evidence of androgenetic alopecia, or male pattern baldness, can be distressing for transgender women. Here we present the case of a transgender woman with scalp hair regrowth after ∼6 months on oral estradiol and spironolactone therapy achieving t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5663205fdd99ce7ab3ea9a3c47f4158
http://europepmc.org/articles/PMC5367483
http://europepmc.org/articles/PMC5367483